CAS: 1356331-63-9
| Marke | Produktdaten | Reinheit | Preisklasse | Voraussichtliche Lieferung |
|---|---|---|---|---|
 | 7-(2,3-Di-p-tolyl-7,8-dihydropyrido[2,3-b]pyrazin-5(6H)-yl)heptanoic acid REF: 3D-GEC33163CAS: 1356331-63-9 | Min. 95% | Nachfragen | Di 26 Nov 24 |
 | QCC-374 REF: TM-T19660CAS: 1356331-63-9 | 98% | 1.386,00 €~2.349,00 € | Di 03 Dez 24 |
![7-(2,3-Di-p-tolyl-7,8-dihydropyrido[2,3-b]pyrazin-5(6H)-yl)heptanoic acid](https://static.cymitquimica.com/products/3D/thumb/GEC33163.jpg)
7-(2,3-Di-p-tolyl-7,8-dihydropyrido[2,3-b]pyrazin-5(6H)-yl)heptanoic acid
CAS:1356331-63-9
7-(2,3-Di-p-tolyl-7,8-dihydropyrido[2,3-b]pyrazin-5(6H)-yl)heptanoic acid is a peptide that belongs to the class of activators. It is used …
Formel:
C28H33N3O2
Reinheit:
Min. 95%
Molekulargewicht:
443.6 g/mol
Ref: 3D-GEC33163
| 25mg | Nachfragen | ||
| 50mg | Nachfragen |
Voraussichtliche Lieferung in Vereinigte Staaten, am Dienstag 26. November 2024
QCC-374
CAS:1356331-63-9
QCC-374 is a prostanoid agonist. It potentially for the treatment of pulmonary arterial hypertension.
Formel:
C28H33N3O2
Reinheit:
98%
Farbe und Form:
Solid
Molekulargewicht:
443.58
Ref: TM-T19660
| 25mg | 1.386,00 € | ||
| 50mg | 1.849,00 € | ||
| 100mg | 2.349,00 € |
Voraussichtliche Lieferung in Vereinigte Staaten, am Dienstag 3. Dezember 2024
